---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-002148"
form_type: "8-K"
ticker: "ANIK"
cik: "0000898437"
company_name: "Anika Therapeutics, Inc."
filed_at: "2025-04-10T23:59:59+00:00"
generated_at: "2026-05-23T17:53:25.544533+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Anika Therapeutics announces departure of COO Anne Nunes, eliminates position

## Summary
- Anne Nunes departs as Chief Operations Officer effective April 25, 2025.
- She receives severance per her Executive Retention Agreement (filed as Exhibit 10.14 to 10-K).
- Stephen Griffin (EVP, CFO, COO) assumes manufacturing and operations functions.
- Company eliminates Chief Operations Officer role; no replacement planned.
- Griffin's annual compensation remains unchanged.

## SEC filing metadata
- accession: 0001171843-25-002148
- form_type: 8-K
- ticker: ANIK
- cik: 0000898437
- company_name: Anika Therapeutics, Inc.
- filed_at: 2025-04-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/898437/000117184325002148/0001171843-25-002148-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/898437/000117184325002148/f8k_041025.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-002148
- JSON: https://secwatch.observer/filing/0001171843-25-002148.json
- Plain text: https://secwatch.observer/filing/0001171843-25-002148.txt

## Key facts
- Executive change
  Anne Nunes departed as Chief Operations Officer at Anika Therapeutics, Inc..
  - Action: departed
  - Role: Chief Operations Officer
  source text: On April 4, 2025, Anika Therapeutics, Inc. (the “Company”) announced the departure of Anne Nunes, Chief Operations Officer, effective April 25, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/898437/000117184325002148/0001171843-25-002148-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.